Chen, R., Gao, X. and Shen, Y. 2024. MiR-3195 inhibits non-small cell lung cancer malignant behaviors along with cisplatin resistance through targeting PFKFB4: MiR-3195 inhibits NSCLC through PFKFB4. Cellular and Molecular Biology. 70, 7 (Jun. 2024).